Sigal Gery

Sigal Gery

Auto-generated profile, based on publicly available information

Sigal Gery

Cedars-Sinai Medical Center, Division of Hematology/Oncology, UCLA School of Medicine, University of California, Los Angeles, CA 90048, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Molecular Cell
Verified
Journal Article
Closed access
SGSigal Gery
Sigal Gery
NKNaoki Komatsu
Naoki Komatsu
LBLilit Baldjyan
Lilit Baldjyan
AYAndrew Yu
Andrew Yu
DKDanielle Koo
Danielle Koo
HKH. Phillip Koeffler
H. Phillip Koeffler

18 June 2007 in Oncogene
Verified
Journal Article
Closed access
PDF file
SGS Gery
S Gery
RVR K Virk
R K Virk
KCK Chumakov
K Chumakov
AYA Yu
A Yu
HKH P Koeffler
H P Koeffler

1 October 2009 in Cancer Research
Verified
Journal Article
Open access
PDF file
QCQi Cao
Qi Cao
SGSigal Gery
Sigal Gery
ADAzadeh Dashti
Azadeh Dashti
DYDong Yin
Dong Yin
YZYan Zhou
Yan Zhou
HKH. Phillip Koeffler
H. Phillip Koeffler
Circadian rhythms regulate diverse physiologic processes, including homeostatic functions of steroid hormones and their receptors. Perturbations of these rhythms are associated with pathogenic conditions, such as depression, diabetes, and cancer. Androgens play an important role in both normal development and carcinogenesis of the prostate. In the present study, we investigated a potential role for the core clock factor Per1 in the pathogenesis of prostate cancer. Serum-shocked synchronized prostate cancer cells displayed disrupted circadian rhythms compared with the normal prostate tissue. Using Oncomine to perform a meta-analysis of microarray expression studies, we found that Per1 is down-regulated in human prostate cancer samples compared with normal prostates. Reporter assays showed that Per1 inhibited transactivation of the androgen receptor (AR) both in 293T cells overexpressing the AR and in the prostate cancer cell line LNCaP. Forced expression of Per1 in LNCaP cells diminished the expression of known androgen-sensitive genes following stimulation with dihydrotestosterone. We showed that Per1 physically interacted with AR; in addition, we found that Per1 itself is regulated by androgens in prostate cancer cells. Overexpression of Per1 in prostate cancer cells resulted in significant growth inhibition and apoptosis. Our results support the emerging role of circadian genes as key players in malignant transformation. Further elucidating the connections between clock genes and the AR pathway could benefit the development of new therapeutic strategies for prostate cancer as well as provide insights into chronotherapy as a way to optimize current therapies. [Cancer Res 2009;69(19):7619–25]

15 October 2005 in Blood
Verified
Journal Article
Open access
PDF file
SGSigal Gery
Sigal Gery
AGAdrian Gombart
Adrian Gombart
WYWilliam S. Yi
William S. Yi
CKChloe Koeffler
Chloe Koeffler
WHWolf-K. Hofmann
Wolf-K. Hofmann
HKH. Phillip Koeffler
H. Phillip Koeffler
CCAAT/enhancer-binding proteins (C/EBPs) are a family of transcription factors that regulate cell growth and differentiation in numerous cell types. To identify novel C/EBP-target genes, we performed transcriptional profiling using inducible NIH 3T3 cell lines expressing 1 of 4 members of the C/EBP family. Functional analysis revealed a previously unknown link between C/EBP proteins and circadian clock genes. Our microarray data showed that the expression levels of 2 core components of the circadian network, Per2 and Rev-Erbα, were significantly altered by C/EBPs. Recent studies suggested that Per2 behaves as a tumor suppressor gene in mice. Therefore, we focused our additional studies on Per2. We showed that Per2 expression is up-regulated by C/EBPα and C/EBPϵ. Per2 levels were reduced in lymphoma cell lines and in acute myeloid leukemia (AML) patient samples. In addition, we generated stable K562 cells that expressed an inducible Per2 gene. Induction of Per2 expression resulted in growth inhibition, cell cycle arrest, apoptosis, and loss of clonogenic ability. These results suggest that Per2 is a downstream C/EBPα-target gene involved in AML, and its disruption might be involved in initiation and/or progression of AML. (Blood. 2005; 106:2827-2836)

1 March 2007 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SGSigal Gery
Sigal Gery
NKNaoki Komatsu
Naoki Komatsu
NKNorihiko Kawamata
Norihiko Kawamata
CMCarl W. Miller
Carl W. Miller
JDJulian Desmond
Julian Desmond
HKH. Phillip Koeffler
H. Phillip Koeffler
Purpose: Epigenetic events are a critical factor contributing to cancer development. The purpose of this study was to identify tumor suppressor genes silenced by DNA methylation and histone deacetylation in non–small cell lung cancer (NSCLC). Experimental Design: We used microarray analysis to screen for tumor suppressor genes. Results: We identified Per1, a core circadian gene, as a candidate tumor suppressor in lung cancer. Although Per1 levels were high in normal lung, its expression was low in a large panel of NSCLC patient samples and cell lines. Forced expression of Per1 in NSCLC cell lines led to significant growth reduction and loss of clonogenic survival. Recent studies showed that epigenetic regulation, particularly histone H3 acetylation, is essential for circadian function. Using bisulfite sequencing and chromatin immunoprecipitation, we found that DNA hypermethylation and histone H3 acetylation are potential mechanisms for silencing Per1 expression NSCLC. Conclusions: These results support the hypothesis that disruption of circadian rhythms plays an important role in lung tumorigenesis. Moreover, our findings suggest a novel link between circadian epigenetic regulation and cancer development.

17 July 2014 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
YZYun Zheng
Yun Zheng
SGSigal Gery
Sigal Gery
HSHaibo Sun
Haibo Sun
SSSharon Shacham
Sharon Shacham
MKMichael Kauffman
Michael Kauffman
HKH. Phillip Koeffler
H. Phillip Koeffler